Clinical Trial Update: Trial of Cemiplimab, or Cemip-Chemo Followed by Biomarker-guided Treatment for Pts w/HPV H&N Ca [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for cemiplimab, with or without chemotherapy, followed by biomarker-guided treatment in HPV-related head and neck squamous cell ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Cemiplimab (cemiplimab)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: HPV-Related Squamous Cell Carcinoma | Phase 2 | Status: RECRUITING